18Mar
17Mar
Disinfectants for Use Against SARS-CoV-2
Portfolio company Simple Science on list from the EPA for Disinfectants for Use Against SARS-CoV-2. Read more >>
14Mar
Testive SAT/ACT Prep to Offer Free Online Practice Tests to High School Students
In an effort to improve education access for those whose schools are closing, Boston-based SAT/ACT prep organization Testive, Inc. will be offering its popular proctored practice SATs and ACTs for free online every Saturday through most of April. Testive is an online test prep organization focusing exclusively on the SAT and ACT. Read more >>
11Mar
Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the appointment of Pete Salzmann, M.D., MBA, to its Board of Directors. Dr. Salzmann brings 20 years of industry experience and currently serves as Chief Executive Officer of Immunovant (IMVT), a biopharmaceutical company focused on developing therapies for patients with autoimmune diseases. Read more >>
10Mar
Emovi Announces the Deployment of KneeKG in Europe with Macopharma, a Worldwide Healthcare Leader
Emovi, Inc., a global medical device company, today announced it has signed an exclusive European distribution agreement with Macopharma for its flagship medical device, KneeKG. Macopharma will be the exclusive KneeKG distributor in Italy, France, Germany, Poland, Spain, and the UK. Read more >>
07Mar
First Patient Dosed in Neuraly’s NLY01 Trial Testing Safety, Efficacy
The first patient has been dosed in a Phase 2 study testing NLY01, an investigational compound with a new mechanism of action designed to stall the progression of Parkinson’s disease. NLY01, being developed by Neuraly, could prevent nerve cell loss in the brain by stopping the toxic activation of immune cells. Read more >>
07Mar
The Top 10 Best IT Resilience Orchestration Solutions for 2020
The editors at Solutions Review have developed this resource to assist buyers in search of the best IT resilience orchestration solutions to fit the needs of their organization. List includes Carbonite. Read more >>
06Mar
Community, students raise money to give gift of sight
Brandon Swallow, a junior at REaCH who is visually impaired, has received eSight glasses to give him 20/20 vision following the third successful fundraiser for the glasses since last December.Read more >>
04Mar
CORRECTING and REPLACING Neuraly Announces First Patient Dosed in Phase 2 Clinical Trial of NLY01 for Patients with Parkinson’s Disease
All mentions of NLY01 have been corrected -- Neuraly, a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced the dosing of the first patient in its Phase 2 clinical trial of NLY01 for Parkinson’s disease. Read more >>
03Mar